Abstract
Non-alcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, and its prevalence is rising in parallel with worldwide increases in obesity and type 2 diabetes. However, the nature of this relationship remains debatable. In particular, it is unclear whether insulin resistance causes NAFLD or hepatic steatosis per se reduces insulin sensitivity. This review will examine data from recent studies on the link between insulin resistance and NAFLD, focusing on studies that have attempted to dissociate fatty liver and hepatic insulin resistance.
Keywords: Non-alcoholic fatty liver disease, Insulin resistance, Triglycerides, Free fatty acids, Steatosis, Mitochondrial dysfunction, Hepatic Fat, Hepatic Steatosis, Pathogenesis, Fat Accumulation, hyperinsulinemia, Lipid Dynamics, Intracellular Signaling, Hepatic Insulin Resistance, methionine and choline deficiency (MCD), very low density lipoprotein (VLDL), insulin receptor substrate (IRS), nuclear factor-kappaB (NFκB)
Current Diabetes Reviews
Title: Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease
Volume: 6 Issue: 5
Author(s): Khalida A. Lockman and Moffat J. Nyirenda
Affiliation:
Keywords: Non-alcoholic fatty liver disease, Insulin resistance, Triglycerides, Free fatty acids, Steatosis, Mitochondrial dysfunction, Hepatic Fat, Hepatic Steatosis, Pathogenesis, Fat Accumulation, hyperinsulinemia, Lipid Dynamics, Intracellular Signaling, Hepatic Insulin Resistance, methionine and choline deficiency (MCD), very low density lipoprotein (VLDL), insulin receptor substrate (IRS), nuclear factor-kappaB (NFκB)
Abstract: Non-alcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, and its prevalence is rising in parallel with worldwide increases in obesity and type 2 diabetes. However, the nature of this relationship remains debatable. In particular, it is unclear whether insulin resistance causes NAFLD or hepatic steatosis per se reduces insulin sensitivity. This review will examine data from recent studies on the link between insulin resistance and NAFLD, focusing on studies that have attempted to dissociate fatty liver and hepatic insulin resistance.
Export Options
About this article
Cite this article as:
A. Lockman Khalida and J. Nyirenda Moffat, Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease, Current Diabetes Reviews 2010; 6 (5) . https://dx.doi.org/10.2174/157339910793360879
DOI https://dx.doi.org/10.2174/157339910793360879 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents on Glioblastoma Signaling
Recent Patents on Biomarkers Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries
Current Pharmaceutical Design Drugs, Environmental Factors, Loci and Genes Involved in Nonsyndromic Orofacial Cleft
Current Pharmacogenomics Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer
Current Drug Delivery Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Current Pharmaceutical Design Novel Classes of Dimer Antitumour Drug Candidates
Current Pharmaceutical Design Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
Current Vascular Pharmacology Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Focus on the Multimodal Role of Biomarkers in Breast Cancer
Current Pharmaceutical Design Molecular Advances Toward the Understanding of the Patho-Biology of Idiopathic Myelofibrosis
Current Immunology Reviews (Discontinued) MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin
Current Cancer Therapy Reviews Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Current Cancer Drug Targets Intracellular Disposition of Methotrexate in Acute Lymphoblastic Leukemia in Children
Current Drug Metabolism Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Medicinal and Beneficial Health Applications of Tinospora cordifolia (Guduchi): A Miraculous Herb Countering Various Diseases/Disorders and its Immunomodulatory Effects
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Retroviral Protein Transfer: Falling Apart to Make an Impact
Current Gene Therapy Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
Current Drug Metabolism Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Current Topics in Medicinal Chemistry